DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Davis Walp

Chief Strategy Officer

Davis brings extensive experiences and tools that will enable him to navigate complex issues and form the growth strategies that will drive new value for DRG’s customers.

Davis Walp joins DRG as Chief Strategy Officer.

Davis has 22 years of global strategy and operations experience spanning pharma, payers, and providers. Davis brings extensive experiences and tools that will enable him to navigate complex issues and form the growth strategies that will drive new value for DRG’s customers.
Prior to joining DRG, Davis was Market Segment Leader at Allscripts, responsible for general management of Allscripts research / research enablement offerings to CROs and pharmaceutical sponsors. Also at Allscripts, Davis was Vice President Strategy and Business Development at 2bPrecise, responsible for precision medicine strategy and partnership development. Prior to Allscripts, Davis was Vice President Market Strategy for Converge HEALTH by Deloitte, responsible for product and customer strategy, client delivery, and collaborative research solutions. Prior to Deloitte, Davis was Head of Value Based Solutions at Quintiles (now IQVIA), responsible for launching a patient engagement solution offering. Prior to Quintiles, Davis spent over a decade at Johnson & Johnson, Pfizer, and GlaxoSmithKline in new product planning and corporate strategy roles.